CorMedix (CRMD) Operating Leases (2019 - 2025)

CorMedix has reported Operating Leases for 7 years, with the latest figure at $2.3 million in Q4 2025.

• Quarterly Operating Leases rose 545.56% year-over-year to $2.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 million (up 545.56% YoY) and the FY2025 annual result came in at $2.3 million, up 545.56% from the prior year.
• Operating Leases slipped to $2.3 million in Q4 2025 per CRMD's latest filing, from $2.4 million in the prior quarter.
• Over five years, Operating Leases peaked at $2.4 million in Q3 2025 and troughed at $258000.0 in Q2 2025.
• A 5-year average of $803773.5 and a median of $685473.5 in 2022 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2021 and 2025: Operating Leases jumped 47205.04% in 2021, then plunged 56.57% in 2025.
• Over 5 years, Operating Leases stood at $802433.0 in 2021, then fell by 16.75% to $668000.0 in 2022, then fell by 22.6% to $517000.0 in 2023, then plunged by 32.5% to $349000.0 in 2024, then surged by 545.56% to $2.3 million in 2025.
• According to Business Quant data, Operating Leases over the past three periods registered $2.3 million, $2.4 million, and $258000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.